SCHEMBL14667432

SCHEMBL14667432

COCCCSCC(=O)Nc1cccc(C)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ POLB P06746 3/20 0.52
▸ HDAC3 O15379 2/20 0.51
▸ HDAC1 Q13547 2/20 0.51
▸ HDAC2 Q92769 2/20 0.51
▸ HDAC10 Q969S8 2/20 0.51
▸ HDAC11 Q96DB2 2/20 0.51
▸ HDAC8 Q9BY41 2/20 0.51
▸ HDAC6 Q9UBN7 2/20 0.51
▸ HDAC4 P56524 1/20 0.51
▸ HDAC7 Q8WUI4 1/20 0.51
▸ HDAC9 Q9UKV0 1/20 0.51
▸ HDAC5 Q9UQL6 1/20 0.51
▸ KMT2A Q03164 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ NCOR2 Q9Y618 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14667390 0.86 DDX3X (0.50) L3MBTL1HDAC3HDAC1HDAC2HDAC10
SCHEMBL14667409 0.84 MAPT (0.55) POLBKMT2AGAAHPGDNPC1
SCHEMBL14667394 0.83 USP2 (0.63) RECQLPOLBHDAC3HDAC1HDAC2
SCHEMBL14667401 0.80 ALOX15 (0.52) RECQLL3MBTL1POLBKMT2AMEN1
SCHEMBL14667389 0.80 MEN1 (0.47) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL15942860 0.80 ALOX15 (0.52) RECQLL3MBTL1POLBKMT2AMEN1
SCHEMBL14948852 0.79 HDAC3 (0.64) L3MBTL1POLBHDAC3HDAC1HDAC2
SCHEMBL14667400 0.78 HPGD (0.52) L3MBTL1POLBKMT2AMEN1HPGD
SCHEMBL14667441 0.78 HSD17B10 (0.47) L3MBTL1POLBHDAC3HDAC1HDAC2
SCHEMBL15942870 0.77 MAPT (0.48) L3MBTL1POLBKMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8802448-B2 Mixed mode ligands PALL CORPORATION (US) 2014-08-12 — — US disclosed
US-20130030154-A1 MIXED MODE LIGANDS PALL CORPORATION (US) 2013-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130030154-A1 MIXED MODE LIGANDS NCL, NECTIN4, NCLN RECQL 1134/4885L3MBTL1 808/4885POLB 1436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback